Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.

DNA Copy Number Variations Genomics Humans Mutation Myeloid Differentiation Factor 88 / genetics Pathology, Molecular Receptors, CXCR4 / genetics Waldenstrom Macroglobulinemia / drug therapy

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
10 04 2020
Historique:
pubmed: 23 2 2020
medline: 29 12 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

Next-generation sequencing has revealed recurring somatic mutations in Waldenström macroglobulinemia (WM), including

Identifiants

DOI: 10.1200/JCO.19.02314 PMID: 32083995 PMC: PMC7351339
pubmed: 32083995
doi: 10.1200/JCO.19.02314
pmc: PMC7351339
doi:

Substances chimiques

CXCR4 protein, human 0
MYD88 protein, human 0
Myeloid Differentiation Factor 88 0
Receptors, CXCR4 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1198-1208

Subventions

Organisme : NCI NIH HHS
ID : P50 CA100707
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Blood Adv. 2018 Nov 13;2(21):2937-2946
pubmed: 30401751
Br J Haematol. 2016 Mar;172(5):735-44
pubmed: 26659815
Nature. 2011 Feb 3;470(7332):115-9
pubmed: 21179087
Leukemia. 2014 Aug;28(8):1698-704
pubmed: 24509637
Lancet Oncol. 2017 Feb;18(2):241-250
pubmed: 27956157
Haematologica. 2017 Dec;102(12):2077-2085
pubmed: 28983055
Leukemia. 2013 Aug;27(8):1722-8
pubmed: 23446312
J Clin Oncol. 2019 Jun 1;37(16):1403-1411
pubmed: 30990729
Leukemia. 2016 May;30(5):1116-25
pubmed: 26867669
Blood. 2013 Mar 14;121(11):2051-8
pubmed: 23321251
Blood. 2014 Mar 13;123(11):1637-46
pubmed: 24366360
Blood Cancer J. 2020 Jan 31;10(1):12
pubmed: 32005797
Blood. 2009 Sep 17;114(12):2375-85
pubmed: 19617573
Am J Hematol. 2017 Aug;92(8):746-751
pubmed: 28383205
N Engl J Med. 2015 Apr 9;372(15):1430-40
pubmed: 25853747
J Clin Oncol. 2017 Mar 20;35(9):994-1001
pubmed: 28294689
Nat Genet. 2003 May;34(1):70-4
pubmed: 12692554
Leukemia. 2018 Dec;32(12):2617-2625
pubmed: 30026568
Br J Haematol. 2019 Mar;184(6):1011-1014
pubmed: 29532913
Blood. 2015 Aug 6;126(6):721-32
pubmed: 26002963
Biol Blood Marrow Transplant. 2019 Mar;25(3):e108-e111
pubmed: 30529461
Br J Haematol. 2019 Nov;187(3):356-363
pubmed: 31267520
Am J Hematol. 2014 Mar;89(3):237-42
pubmed: 24716234
Nature. 2018 Aug;560(7718):387-391
pubmed: 29925955
Br J Haematol. 2019 Jan;184(2):242-245
pubmed: 30183082
Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e496-e505
pubmed: 31221512
Leukemia. 2015 Jan;29(1):169-76
pubmed: 24912431
Blood. 2015 Sep 10;126(11):1392-4
pubmed: 26359434
N Engl J Med. 2015 Aug 6;373(6):584-6
pubmed: 26244327
J Cutan Pathol. 2017 Jul;44(7):625-631
pubmed: 28370087
Blood. 2003 Feb 15;101(4):1570-1
pubmed: 12393502
Blood. 2013 May 30;121(22):4504-11
pubmed: 23532735
Blood. 2014 May 1;123(18):2791-6
pubmed: 24553177
Clin Cancer Res. 2017 May 15;23(10):2400-2404
pubmed: 27836860
Br J Haematol. 2016 Aug;174(4):645-8
pubmed: 26523929
Blood. 2014 Jun 26;123(26):4120-31
pubmed: 24711662
Blood. 2016 Jun 23;127(25):3237-52
pubmed: 27143257
J Clin Oncol. 2010 May 1;28(13):2227-32
pubmed: 20368570
Am J Hematol. 2018 Feb;93(2):187-194
pubmed: 29080258
Clin Cancer Res. 2017 Oct 15;23(20):6325-6335
pubmed: 28754818
Ann Hematol. 2018 Aug;97(8):1417-1425
pubmed: 29610969
Br J Haematol. 2018 Feb;180(3):374-380
pubmed: 29181840
Clin Cancer Res. 2016 Mar 15;22(6):1480-8
pubmed: 26490317
Br J Haematol. 2015 Mar;168(5):701-7
pubmed: 25371371
Haematologica. 2018 Sep;103(9):e408-e411
pubmed: 29599202
J Clin Oncol. 2017 Mar 10;35(8):826-833
pubmed: 28095146
Blood. 2013 Sep 26;122(13):2284-5
pubmed: 24072850
Nature. 2010 Jun 17;465(7300):885-90
pubmed: 20485341
Br J Haematol. 2018 Apr;181(1):77-85
pubmed: 29468652
Br J Haematol. 2014 Nov;167(4):506-13
pubmed: 25160558
Blood. 2018 Dec 13;132(24):2608-2612
pubmed: 30366921
Blood Adv. 2019 May 14;3(9):1553-1562
pubmed: 31088809
N Engl J Med. 2012 Aug 30;367(9):826-33
pubmed: 22931316
Nature. 2010 Jan 7;463(7277):88-92
pubmed: 20054396
Blood. 2013 Mar 28;121(13):2522-8
pubmed: 23355535
Lancet. 2013 Apr 6;381(9873):1203-10
pubmed: 23433739
Br J Haematol. 2013 Jun;161(6):902-4
pubmed: 23560587
Blood Cancer J. 2017 Aug 25;7(8):e591
pubmed: 28841204
Br J Haematol. 2019 Jul;186(1):146-149
pubmed: 30548257
Haematologica. 2018 Jun;103(6):1029-1037
pubmed: 29567768
Blood. 2013 Aug 15;122(7):1222-32
pubmed: 23836557
Clin Cancer Res. 2018 Jul 15;24(14):3247-3252
pubmed: 29661775
J Clin Oncol. 2018 Sep 20;36(27):2755-2761
pubmed: 30044692
Blood. 2017 May 4;129(18):2519-2525
pubmed: 28235842
N Engl J Med. 2018 Jun 21;378(25):2399-2410
pubmed: 29856685
Blood. 2016 Sep 8;128(10):1321-8
pubmed: 27432877
Blood. 2014 Jul 24;124(4):503-10
pubmed: 24859363
Leukemia. 2015 Dec;29(12):2338-46
pubmed: 26139427
Blood. 2018 Apr 12;131(15):1720-1729
pubmed: 29358175
Am J Hematol. 2015 Jun;90(6):E122-3
pubmed: 25703132
Blood. 2017 Jan 26;129(4):456-459
pubmed: 27872060
Blood. 2015 Apr 9;125(15):2370-80
pubmed: 25655603
Lancet Haematol. 2017 Jan;4(1):e24-e34
pubmed: 27914971
Blood. 2018 Jan 18;131(3):368-371
pubmed: 29180400
Virchows Arch. 2016 Mar;468(3):259-75
pubmed: 26454445
Br J Haematol. 2017 Mar;176(5):822-824
pubmed: 26936399
J Exp Med. 1998 Apr 20;187(8):1343-8
pubmed: 9547345
Br J Haematol. 2013 Jan;160(2):171-6
pubmed: 23150997
Br J Haematol. 2018 Feb;180(4):578-581
pubmed: 27748515

Auteurs

Steven P Treon (SP)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Lian Xu (L)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Maria Luisa Guerrera (ML)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Cristina Jimenez (C)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Zachary R Hunter (ZR)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Xia Liu (X)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Maria Demos (M)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Joshua Gustine (J)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Gloria Chan (G)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Manit Munshi (M)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Nicholas Tsakmaklis (N)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Jiaji G Chen (JG)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Amanda Kofides (A)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Romanos Sklavenitis-Pistofidis (R)

Department of Medicine, Harvard Medical School, Boston, MA.
Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
Clinical Research Development and Phase I Unit, CREA Laboratory, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Italy.

Mark Bustoros (M)

Department of Medicine, Harvard Medical School, Boston, MA.
Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.

Andrew Keezer (A)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Kirsten Meid (K)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Christopher J Patterson (CJ)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.

Antonio Sacco (A)

Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
Clinical Research Development and Phase I Unit, CREA Laboratory, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Italy.

Aldo Roccaro (A)

Clinical Research Development and Phase I Unit, CREA Laboratory, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Italy.

Andrew R Branagan (AR)

Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA.

Guang Yang (G)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Irene M Ghobrial (IM)

Department of Medicine, Harvard Medical School, Boston, MA.
Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.

Jorge J Castillo (JJ)

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Variation structurale du génome › Variations de nombre de copies de segment d'ADN › Genomic Landscape of Waldenström...
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Génétique › Génomique › Genomic Landscape of Waldenström...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Genomic Landscape of Waldenström...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Genomic Landscape of Waldenström...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Protéines adaptatrices de la transduction du signal › Facteur de différenciation myéloïde-88 › Genomic Landscape of Waldenström...
questionsmedicales.fr › Professions de santé › Médecine › Anatomopathologie › Anatomopathologie moléculaire › Genomic Landscape of Waldenström...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs viraux › Récepteur VIH › Récepteurs CXCR4 › Genomic Landscape of Waldenström...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Paraprotéinémies › Macroglobulinémie de Waldenström › Genomic Landscape of Waldenström...